TITLE

Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia

AUTHOR(S)
Turner, Barbara J.; Md; Markson, Leona; Cocroft, James; Cosler, Leon; Hauck, Walter W.; Turner; Turner, B J; Markson, L; Cocroft, J; Cosler, L; Hauck, W W
PUB. DATE
January 1998
SOURCE
JGIM: Journal of General Internal Medicine;Jan1998, Vol. 13 Issue 1, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Objective: To examine the association of clinic HIV-focused features and advanced HIV care experience with Pneumocystis carinii pneumonia (PCP) prophylaxis and development of PCP as the initial AIDS diagnosis.Design: Nonconcurrent prospective study.Setting: New York State Medicaid Program.Participants: Medicaid enrollees diagnosed with AIDS in 1990-1992.Measurements and Main Results: We collected patient clinical and health care data from Medicaid files, conducted telephone interviews of directors of 125 clinics serving as the usual source of care for study patients, and measured AIDS experience as the cumulative number of AIDS patients treated by the study clinics since 1986. Pneumocystis carinii pneumonia prophylaxis in the 6 months before AIDS diagnosis and PCP at AIDS diagnosis were the main outcome measures. Bivariate and multivariate analyses adjusted for clustering of patients within clinics. Of 1,876 HIV-infected persons, 44% had PCP prophylaxis and 38% had primary PCP. Persons on prophylaxis had 20% lower adjusted odds of developing PCP (95% confidence interval [CI] 0.64, 0.99). The adjusted odds of receiving prophylaxis rose monotonically with the number of HIV-focused features offered by the clinic, with threefold higher odds (95% CI 1.6, 5.7) for six versus two or fewer such features. Patients in clinics with three HIV-focused features had 36% lower adjusted odds of PCP than those in clinics with one or none. Neither clinic experience nor specialty had a significant association with prophylaxis or PCP.Conclusions: PCP prevention in our study cohort appears to be more successful in clinics offering an array of HIV-focused features.
ACCESSION #
5527885

 

Related Articles

  • Pneumocystis carinii.  // Columbia Electronic Encyclopedia, 6th Edition;Feb2013, p1 

    Pneumocystis carinii: see pneumonia.

  • Pneumocystis carinii.  // Columbia Electronic Encyclopedia, 6th Edition;Q1 2017, p1 

    Pneumocystis carinii: see pneumonia.

  • New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. Kovacs, Joseph A.; Gill, Vee J.; Meshnick, Steven; Masur, Henry // JAMA: Journal of the American Medical Association;11/21/2001, Vol. 286 Issue 19, p2450 

    Presents a case of Pneumocystis carinii infection that typifies clinical presentation in the era of the AIDS and HIV epidemics. Discussion of the biology and epidemiology of P. carinii; History and diagnosis of pneumocystis carinii pneumonia (PCP); Prevention of PCP; Sulfa drug-resistance in P....

  • Pneumocystis carinii Pneumonia: A Cluster of Eleven Cases. Singer, Carol; Armstrong, Donald; Rosen, Paul Peter; Schottenfeld, David // Annals of Internal Medicine;Jun75, Vol. 82 Issue 6, p772 

    Describes several cases of pneumocystis carinii pneumonia. Methodology; Clinical observations; Discussion.

  • Pneumocystis carinii Pneumonia in the United States. Walzer, Peter D.; Perl, Daniel P.; Krogstad, Donald J.; Rawson, Perry G.; Schultz, Myron G. // Annals of Internal Medicine;Jan74, Vol. 80 Issue 1, p83 

    Provides information on patients with confirmed Pneumocystis carinii pneumonia in the U.S. Nature of P. carinii pneumonia; Efficacy of pentamidine in the treatment of pneumocystis pneumonia; Diagnostic features of P. carinii pneumonia; Frequency of P. carinii pneumonia in patients with selected...

  • A New Name (Pneumocystis jiroveci) for Pneumocystis from Humans. Stringer, James R.; Beard, Charles B.; Miller, Robert F.; Wakefield, Ann E. // Emerging Infectious Diseases;Sep2002, Vol. 8 Issue 9, p891 

    Discusses the renaming of the Pneumocystis organism that cause Pneumocystis carinii pneumonia in humans to Pneumocystis jiroveci Frenkel in 1999. Clinical importance of Pneumocystis; Reason for the need for change in nomenclature of Pneumocystis; Genetic differences between Pneumocystis and P....

  • Pneumocystis carinii Pneumonia (or PCP).  // American Family Physician;10/15/1999, Vol. 60 Issue 6, p1 

    Provides information on Pneumocystis carinii pneumonia (PCP). Definition of PCP; Symptoms of PCP; Medication for PCP prevention.

  • Detection of Pneumocystis carinii DNA in the Air Filter of a Ventilated Patient with AIDS. Sing, Andreas; Wonhas, Christoph; Bader, Lutz; Luther, Martin; Heesemann, J&uumi;rgen // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p952 

    Presents a case report of Pneumocystis carinii DNA isolated from the air filter of a ventilated AIDS patient with Pneumocystis carinii pneumonia. Clinical history of the patient; Management of the disease; Clinical significance of the case report.

  • Pneumocystis carinii Pneumonia Preceding Childhood Lvmphoma. Jong-Jin Seo; Ghim, Thad T. // Clinical Pediatrics;Feb1993, Vol. 32 Issue 2, p126 

    Presents a letter to the editor of the periodical "Clinical Pediatrics" about an article on pneumocystis carinii pneumonia preceding childhood lymphoma.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics